Why the study?
Does antihypertensive medication use reduce carotid IMT and plaque progression in a multiethnic cohort?
Does antihypertensive medication use reduce carotid IMT and plaque progression in a multiethnic cohort?
Ethnicity and antihypertensive medication use are significant predictors of long-term carotid IMT and plaque progression.
Ethnicity informs carotid risk stratification; leaves open causal antihypertensive effects on progression.
In a large, multiethnic cohort with a decade of follow-up, ethnicity was a strong, independent predictor of carotid IMT and plaque progression. Antihypertensive medication use was associated with less subclinical disease progression.
No takes yet. Share an insight, caveat, or question.
Tattersall et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: